Cardinal Health, Inc.

🇺🇸New York Stock Exchange
Back to all articles
Cardinal Health, Inc. stock analysis CAH overview
Neutral 0

Cardinal: Fiscal Q3 Earnings Snapshot

💰 Cardinal Health reported fiscal Q3 net income of $399 million, beating Wall Street expectations.

📈 Adjusted earnings came in at $3.17 per share compared to an analyst consensus of $2.80.

⚠️ Revenue for the quarter reached $60.94 billion, falling short of the estimated $62.35 billion forecast.

💼 Profit on a per-share basis was reported at $1.69 following the standard accounting adjustments.

📅 The company projects full-year earnings will range between $10.70 and $10.80 per share.

📉 Cardinal shares have declined over 1% since the start of the year despite a gain of 45% in the last 12 months.

📊 The broader S&P 500 index has risen by 4%, highlighting a performance divergence for the stock.

📋 These financial results were provided by Cardinal Health Inc., a Dublin, Ohio-based prescription drug distributor.

Bullish Signals
  • Despite a slight miss in revenue, Cardinal shares have gained 45% over the last 12 months, demonstrating resilience and long-term value creation for shareholders.
Risk Factors
  • Revenue of $60.94 billion missed Street forecasts, with analysts surveyed by Zacks expecting $62.35 billion.
  • Cardinal shares have dropped slightly more than 1% since the beginning of the year, trailing the S&P's 500 index which has climbed 4% during the same period.
Full Analysis
Cardinal Health Inc. (CAH) reported fiscal third-quarter earnings of $399 million, translating to a profit of $1.69 per share for the company headquartered in Dublin, Ohio. When adjusting for specific factors such as asset impairment costs and merger-related expenses, the adjusted earnings increased to $3.17 per share. These financial results exceeded the expectations set by Wall Street analysts, with Zacks Investment Research surveying eight experts who had projected an average earnings figure of $2.80 per share. However, despite the strong earnings beat, the company's revenue performance did not meet forecasts; Cardinal posted total revenue of $60.94 billion for the period, falling short of the $62.35 billion expected by six analysts surveyed by Zacks. Looking ahead to the full year, Cardinal Health anticipates earnings per share in a range between $10.70 and $10.80. The report also provides context on the company's stock performance relative to broader market indices, noting that Cardinal shares have declined slightly more than 1% since the beginning of the year while the S&P 500 index has risen by 4%. Over the past 12 months, however, the stock has gained approximately 45%. This financial snapshot was generated using data from Zacks Investment Research and highlights the mixed results where profitability surpassed expectations but top-line revenue growth lagged behind analyst projections.